As the focus turns from basic biological research to clinical pharmacology, understanding opportunities presented through integration of nanotechnology and biotechnology is critical to drive future growth.
BioIntel360’s Nanobiotechnology offering provides an in-depth analysis to cut through the hype and provide investors and companies with a realistic assessment of technology's commercial potential through sector specific predictive analytics. In addition, it helps decode applications in various industries together with a market outlook and examining different trends, drivers, and constraints, as well as how the market will perform in the coming years.
| Insight Type | Report Title | Publish Date ? | Action |
|---|---|---|---|
 Databook |
Middle East & Africa Diabetes Devices and Therapeutics Business Opportunities Databook – Q2 2023 Update
According to BioIntel360, Middle East and Africa diabetes devices market size is expected to record... |
Jan 01,1970 | View |
